Engineering graded tissue interfaces.

Proceedings of the National Academy of Sciences of the United States of America
Jennifer E PhillipsAndrés J García

Abstract

Interfacial zones between tissues provide specialized, transitional junctions central to normal tissue function. Regenerative medicine strategies focused on multiple cell types and/or bi/tri-layered scaffolds do not provide continuously graded interfaces, severely limiting the integration and biological performance of engineered tissue substitutes. Inspired by the bone-soft tissue interface, we describe a biomaterial-mediated gene transfer strategy for spatially regulated genetic modification and differentiation of primary dermal fibroblasts within tissue-engineered constructs. We demonstrate that zonal organization of osteoblastic and fibroblastic cellular phenotypes can be engineered by a simple, one-step seeding of fibroblasts onto scaffolds containing a spatial distribution of retrovirus encoding the osteogenic transcription factor Runx2/Cbfa1. Gradients of immobilized retrovirus, achieved via deposition of controlled poly(L-lysine) densities, resulted in spatial patterns of transcription factor expression, osteoblastic differentiation, and mineralized matrix deposition. Notably, this graded distribution of mineral deposition and mechanical properties was maintained when implanted in vivo in an ectopic site. Development of ...Continue Reading

References

Jun 29, 1999·Nature Biotechnology·L D SheaD J Mooney
Apr 4, 2003·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Shuying YangRenny T Franceschi
Apr 23, 2003·Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society·Stavros ThomopoulosLouis J Soslowsky
Sep 2, 2003·Pharmaceutical Research·Ruth R Chen, David J Mooney
Dec 13, 2003·Tissue Engineering·Sarah H CartmellRobert E Guldberg
Feb 18, 2004·Annals of Biomedical Engineering·Blanka Sharma, Jennifer H Elisseeff
Jul 6, 2004·Molecular Therapy : the Journal of the American Society of Gene Therapy·Angela K Pannier, Lonnie D Shea
Dec 18, 2004·Biomaterials·Solitaire A DeLongJennifer L West
Nov 8, 2005·Journal of Biomechanics·Savio L-Y WooRui Liang
Nov 16, 2005·Journal of Biomedical Materials Research. Part a·Benjamin A ByersAndrés J García
Jan 31, 2006·Journal of Cell Science·Jennifer E PhillipsAndrés J García
Feb 24, 2006·Gene Therapy·C A GersbachA J García
Jul 22, 2006·Biomaterials·Jennifer E PhillipsAndrés J García
Dec 28, 2006·Pharmaceutical Research·Ruth R ChenDavid J Mooney
May 24, 2007·Tissue Engineering·Antonios G MikosGordana Vunjak-Novakovic
Aug 7, 2007·Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society·I-Ning E WangHelen H Lu
Sep 1, 2007·Langmuir : the ACS Journal of Surfaces and Colloids·Maniya MalekiRamin Golestanian

❮ Previous
Next ❯

Citations

Apr 10, 2010·Annals of Biomedical Engineering·Nathan H DormerMichael S Detamore
Apr 23, 2010·Annals of Biomedical Engineering·Nathan H DormerMichael S Detamore
May 1, 2010·Annals of Biomedical Engineering·Jennifer Z PaxtonLiam M Grover
Apr 28, 2010·Annals of Biomedical Engineering·Helen H LuXinzhi Zhang
Sep 7, 2012·Langmuir : the ACS Journal of Surfaces and Colloids·Walter BonaniWei Tan
Sep 3, 2010·Molecular Therapy : the Journal of the American Society of Gene Therapy·Morten Ø AndersenJørgen Kjems
Jun 2, 2011·Molecular Therapy : the Journal of the American Society of Gene Therapy·Jae-Hyung JangLonnie D Shea
Nov 27, 2009·Nature·Nathaniel Huebsch, David J Mooney
Dec 13, 2012·Nature Communications·Rafael LibanoriAndré R Studart
Aug 9, 2012·Proceedings of the National Academy of Sciences of the United States of America·Brendon M BakerRobert L Mauck
Jul 3, 2010·Tissue Engineering. Part a·Jennifer Z PaxtonKeith Baar
Apr 26, 2011·Tissue Engineering. Part a·Natalja E FedorovichJacqueline Alblas
Feb 24, 2009·Tissue Engineering. Part B, Reviews·Peter J Yang, Johnna S Temenoff
Nov 16, 2012·Tissue Engineering. Part B, Reviews·Tong Ming Liu, Eng Hin Lee
May 7, 2013·Annual Review of Biomedical Engineering·Helen H Lu, Stavros Thomopoulos
Jan 31, 2012·Journal of Biomaterials Applications·Murugan RamalingamCarl G Simon
Jan 25, 2012·International Journal of Molecular Sciences·Saumendra BajpaiCynthia A Reinhart-King
Dec 27, 2012·Biotechnology Advances·Janna C Nawroth, Kevin Kit Parker
Nov 6, 2013·Tissue Engineering. Part C, Methods·Chan Ho ParkWilliam V Giannobile
Apr 22, 2015·Annual Review of Virology·Vyas RamananSangeeta N Bhatia
May 28, 2015·Journal of Biomedical Materials Research. Part a·Neethu MohanPrabha D Nair
Jun 27, 2013·Journal of Tissue Engineering and Regenerative Medicine·Wei-Wen HuPaul H Krebsbach
Dec 22, 2011·Connective Tissue Research·Lester SmithStavros Thomopoulos
Nov 5, 2013·Mayo Clinic Proceedings·Christopher H Evans
Dec 3, 2014·Advanced Drug Delivery Reviews·Julia E Samorezov, Eben Alsberg
Dec 25, 2012·Journal of the Mechanical Behavior of Biomedical Materials·Josephine P F WongRobert A Brown
Oct 14, 2011·Biomaterials·Chan Ho ParkWilliam V Giannobile
Dec 24, 2010·Biomaterials·Yaseen M ElkasabiPaul H Krebsbach
Mar 18, 2015·Advanced Drug Delivery Reviews·Sonia Font TelladoMartijn Van Griensven
Mar 11, 2009·Journal of Tissue Engineering and Regenerative Medicine·E HadjipanayiV Mudera
Oct 1, 2013·Birth Defects Research. Part C, Embryo Today : Reviews·Guang YangRocky S Tuan
Mar 26, 2010·Journal of Biomedical Materials Research. Part a·Milind SinghMichael S Detamore
Aug 30, 2011·The Canadian Journal of Chemical Engineering·Shilpa SantAli Khademhosseini
Mar 30, 2012·Birth Defects Research. Part C, Embryo Today : Reviews·Nianli Zhang, David H Kohn
Aug 31, 2010·Biotechnology and Bioengineering·Jeremy J LimJohnna S Temenoff
Oct 15, 2009·Journal of Biomedical Materials Research. Part a·Seungjin ShinLonnie D Shea

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.